ARFGAP3 and Familial prostate cancer: Gene combinations of OBSCN, FAM83H, CLDN7 and ARFGAP3 significantly predicted the risk of re-occurrence after treatment, demonstrating that the genes identified through this screen can have high predictive value in patients and thus are potential prostate cancer biomarkers.